Clinical Trial Update: Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dolutegravir/lamivudine dual therapy in ART-naïve people with HIV who are receiving rifampin-based tuberculosis treatment. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Dolutegravir/Lamivudine (dolutegravir/lamivudine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Tuberculosis, HIV | Phase 3 | Status: RECRUITING